Thomas Kurian Sold 979402 shares of Oracle (ORCL) in an Insider Trade; CASTLIGHT HEALTH Has 1.23 Sentiment

Oracle Corporation (NYSE:ORCL) Logo

CASTLIGHT HEALTH (CSLT) investors sentiment decreased to 1.23 in Q4 2017. It’s down -0.82, from 2.05 in 2017Q3. The ratio fall, as 38 active investment managers increased and started new positions, while 31 trimmed and sold equity positions in CASTLIGHT HEALTH. The active investment managers in our database reported: 46.25 million shares, up from 44.86 million shares in 2017Q3. Also, the number of active investment managers holding CASTLIGHT HEALTH in top ten positions was flat from 0 to 0 for the same number . Sold All: 10 Reduced: 21 Increased: 22 New Position: 16.

The stock increased 1.44% or $0.65 during the last trading session, reaching $45.71. About 10.57M shares traded. Oracle Corporation (NYSE:ORCL) has risen 1.20% since May 5, 2017 and is uptrending. It has underperformed by 10.35% the S&P500.

Unloading amounting to exactly $44,461,408 U.S. Dollars was published in a public report submitted to the Security Exchange Commission on May 04, 2018. According to which, Thomas Kurian, the President-Product Development of Oracle Corp also an insider of the California-based company had sold exactly 979,402 shares – ( at $45.4 per every share ). This is not his first insider trade, in the last month, he sold another 520,598 shares worth $23,984,360 USD. Currently, Mr. Thomas, has 22,983 shares, which accounts for 0.0006% of Oracle Corp’s market cap. The insider’s activity definitely generated quite an interest in the stock community.

Analysts await Oracle Corporation (NYSE:ORCL) to report earnings on June, 20. They expect $0.86 earnings per share, up 4.88% or $0.04 from last year’s $0.82 per share. ORCL’s profit will be $3.51 billion for 13.29 P/E if the $0.86 EPS becomes a reality. After $0.75 actual earnings per share reported by Oracle Corporation for the previous quarter, Wall Street now forecasts 14.67% EPS growth.

Among 42 analysts covering Oracle (NYSE:ORCL), 27 have Buy rating, 0 Sell and 15 Hold. Therefore 64% are positive. Oracle has $65 highest and $37 lowest target. $54.02’s average target is 18.18% above currents $45.71 stock price. Oracle had 115 analyst reports since July 30, 2015 according to SRatingsIntel. As per Tuesday, March 20, the company rating was maintained by Credit Suisse. The company was initiated on Tuesday, April 26 by Macquarie Research. On Thursday, June 22 the stock rating was upgraded by Wedbush to “Outperform”. The stock has “Buy” rating by Stifel Nicolaus on Friday, December 16. Bank of America downgraded the stock to “Neutral” rating in Tuesday, March 20 report. On Thursday, July 30 the stock rating was upgraded by Jefferies to “Buy”. On Monday, October 2 the stock rating was maintained by BMO Capital Markets with “Buy”. The stock of Oracle Corporation (NYSE:ORCL) earned “Hold” rating by Wunderlich on Thursday, September 17. The stock of Oracle Corporation (NYSE:ORCL) has “Sector Weight” rating given on Friday, June 17 by Pacific Crest. The stock of Oracle Corporation (NYSE:ORCL) earned “Outperform” rating by BMO Capital Markets on Friday, September 16.

Oracle Corporation develops, manufactures, markets, sells, hosts, and supports application, platform, and infrastructure technologies for information technology environments worldwide. The company has market cap of $186.60 billion. It provides services in three primary layers of the cloud: Software as a Service, Platform as a Service, and Infrastructure as a Service. It has a 53.46 P/E ratio. The firm licenses its Oracle Database software, which enables storage, retrieval, and manipulation of data; and Oracle Fusion Middleware software to build, deploy, secure, access, and integrate business applications, as well as automate their business processes.

Investors sentiment increased to 1.15 in Q4 2017. Its up 0.02, from 1.13 in 2017Q3. It increased, as 80 investors sold Oracle Corporation shares while 488 reduced holdings. 126 funds opened positions while 526 raised stakes. 2.29 billion shares or 1.37% less from 2.32 billion shares in 2017Q3 were reported. Cornerstone Investment Partners Ltd Com invested in 3.69 million shares or 3.8% of the stock. Founders Capital Mngmt Lc holds 5,724 shares. Heartland Advisors invested in 0.59% or 194,571 shares. Pacific Global Investment Communication reported 0.57% of its portfolio in Oracle Corporation (NYSE:ORCL). 16,066 are held by Bailard. Ifrah Financial Ser stated it has 0.4% in Oracle Corporation (NYSE:ORCL). Interocean Ltd Limited Liability Company has 0.03% invested in Oracle Corporation (NYSE:ORCL). Wedgewood Incorporated Pa reported 0.17% in Oracle Corporation (NYSE:ORCL). Davenport & Com Ltd Limited Liability Company has invested 0.48% in Oracle Corporation (NYSE:ORCL). Alabama-based Kistler has invested 0.12% in Oracle Corporation (NYSE:ORCL). Foster Dykema Cabot Company Inc Ma stated it has 0.07% in Oracle Corporation (NYSE:ORCL). Smith Chas P Associate Pa Cpas reported 0.56% of its portfolio in Oracle Corporation (NYSE:ORCL). Altavista Wealth Incorporated accumulated 0.19% or 9,700 shares. Cwm Ltd stated it has 0.31% in Oracle Corporation (NYSE:ORCL). Scharf Invs Llc holds 5.43M shares.

Since December 15, 2017, it had 0 buys, and 14 selling transactions for $377.33 million activity. $250.23 million worth of Oracle Corporation (NYSE:ORCL) shares were sold by CATZ SAFRA. Kurian Thomas had sold 57,155 shares worth $2.63 million. On Thursday, March 15 GARCIA-MOLINA HECTOR sold $195,713 worth of Oracle Corporation (NYSE:ORCL) or 3,750 shares. Daley Dorian also sold $5.20M worth of Oracle Corporation (NYSE:ORCL) shares. BERG JEFFREY sold $3.45 million worth of stock. SELIGMAN NAOMI O sold $2.31M worth of Oracle Corporation (NYSE:ORCL) on Wednesday, January 24.

More notable recent Oracle Corporation (NYSE:ORCL) news were published by: which released: “Oracle’s Cloud Transition Doesn’t Match Other Success Stories” on May 03, 2018, also with their article: “Oracle acquires ad targeting company Grapeshot” published on April 24, 2018, published: “Oracle Corp.: Tech Bounce Opportunity” on April 06, 2018. More interesting news about Oracle Corporation (NYSE:ORCL) were released by: and their article: “Now Is The Time To Buy Oracle” published on April 09, 2018 as well as‘s news article titled: “Oracle CEO admits to cloud contract discussion with Trump” with publication date: April 16, 2018.

Gagnon Advisors Llc holds 2.48% of its portfolio in Castlight Health, Inc. for 901,394 shares. Gagnon Securities Llc owns 1.47 million shares or 1.96% of their US portfolio. Moreover, Selz Capital Llc has 0.41% invested in the company for 734,000 shares. The United Kingdom-based Wellcome Trust Ltd (The) As Trustee Of The Wellcome Trust has invested 0.37% in the stock. Allen Operations Llc, a New York-based fund reported 157,372 shares.

The stock increased 1.32% or $0.05 during the last trading session, reaching $3.85. About 256,764 shares traded. Castlight Health, Inc. (CSLT) has risen 6.15% since May 5, 2017 and is uptrending. It has underperformed by 5.40% the S&P500.

Since January 1, 0001, it had 0 buys, and 4 insider sales for $120,817 activity.

Castlight Health, Inc. (NYSE:CSLT) Institutional Positions Chart